| 000 | 01736 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250512010109.0 | ||
| 264 | 0 | _c19850425 | |
| 008 | 198504s 0 0 eng d | ||
| 022 | _a0022-3565 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGil, D W | |
| 245 | 0 | 0 |
_aPirenzepine distinguishes between muscarinic receptor-mediated phosphoinositide breakdown and inhibition of adenylate cyclase. _h[electronic resource] |
| 260 |
_bThe Journal of pharmacology and experimental therapeutics _cMar 1985 |
||
| 300 |
_a608-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_a(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride _xpharmacology |
| 650 | 0 | 4 |
_aAcetylcholine _xpharmacology |
| 650 | 0 | 4 | _aAdenylyl Cyclase Inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAtropine _xpharmacology |
| 650 | 0 | 4 |
_aBenzodiazepinones _xpharmacology |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aCarbachol _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 |
_aInositol _xanalogs & derivatives |
| 650 | 0 | 4 | _aInositol Phosphates |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocardium _xmetabolism |
| 650 | 0 | 4 |
_aOxotremorine _xpharmacology |
| 650 | 0 | 4 |
_aParotid Gland _xmetabolism |
| 650 | 0 | 4 |
_aPhosphatidylinositols _xmetabolism |
| 650 | 0 | 4 | _aPirenzepine |
| 650 | 0 | 4 |
_aQuinuclidinyl Benzilate _xmetabolism |
| 650 | 0 | 4 | _aRadioligand Assay |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Inbred Strains |
| 650 | 0 | 4 |
_aReceptors, Muscarinic _xdrug effects |
| 700 | 1 | _aWolfe, B B | |
| 773 | 0 |
_tThe Journal of pharmacology and experimental therapeutics _gvol. 232 _gno. 3 _gp. 608-16 |
|
| 999 |
_c2585128 _d2585128 |
||